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Immortalized N/TERT 
keratinocytes as an alternative 
cell source in 3D human epidermal 
models
Jos P. H. Smits  1, Hanna Niehues1, Gijs Rikken1, Ivonne M. J. J. van Vlijmen-Willems1, 
Guillaume W. H. J. F. van de Zande2, Patrick L. J. M. Zeeuwen1, Joost Schalkwijk1 & Ellen H. 
van den Bogaard1
The strong societal urge to reduce the use of experimental animals, and the biological differences 
between rodent and human skin, have led to the development of alternative models for healthy 
and diseased human skin. However, the limited availability of primary keratinocytes to generate 
such models hampers large-scale implementation of skin models in biomedical, toxicological, 
and pharmaceutical research. Immortalized cell lines may overcome these issues, however, few 
immortalized human keratinocyte cell lines are available and most do not form a fully stratified 
epithelium. In this study we compared two immortalized keratinocyte cell lines (N/TERT1, N/TERT2G) 
to human primary keratinocytes based on epidermal differentiation, response to inflammatory 
mediators, and the development of normal and inflammatory human epidermal equivalents (HEEs). 
Stratum corneum permeability, epidermal morphology, and expression of epidermal differentiation 
and host defence genes and proteins in N/TERT-HEE cultures was similar to that of primary human 
keratinocytes. We successfully generated N/TERT-HEEs with psoriasis or atopic dermatitis features and 
validated these models for drug-screening purposes. We conclude that the N/TERT keratinocyte cell 
lines are useful substitutes for primary human keratinocytes thereby providing a biologically relevant, 
unlimited cell source for in vitro studies on epidermal biology, inflammatory skin disease pathogenesis 
and therapeutics.
In vitro cultured 3D human skin equivalents (HSEs) and human epidermal equivalents (HEEs) (also known as 
organotypic skin models) are nowadays often used for studies in the fields of cell biology, tissue engineering, der-
matology, and toxicology. These 3D skin models are preferred over the conventional monolayer cultures as they 
faithfully mimic the in vivo epidermis and skin barrier function and thereby serve as alternatives for experimental 
animal testing1. To meet the growing demand for these in vitro 3D human organotypic skin cultures, large quan-
tities of primary keratinocytes are required. Human primary keratinocytes are preferably isolated from adult skin 
excised during plastic surgery (e.g. abdominal wall or breast reduction). Unfortunately, the availability of donor 
skin is limited and the short in vitro lifespan and inter-donor variation are disadvantages of the use of human 
primary keratinocytes. Immortalized keratinocyte cell lines could therefore provide an unlimited cell source and 
solution to the aforementioned issues.
The HaCaT cell line, a spontaneously immortalized human keratinocyte cell line, is widely used in keratino-
cyte monolayer culture models and also described for the development of organotypic skin models2. HaCaT cells 
respond to differentiation-promoting stimuli, such as contact inhibition and high calcium concentrations in the 
culture medium2–4. However, the transcriptional expression pattern of cornified envelope-associated proteins, 
such as filaggrin, loricrin and involucrin is abnormal compared to normal human primary keratinocytes5,6 and 
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karyotyping of HaCaT cells shows aneuploidy5. Wound regeneration and eczematous organotypic models with 
HaCaT cells have been reported6–10, however, epidermal stratification is abnormal, aberrant epidermal differen-
tiation protein expression is observed and a stratum corneum is lacking in these HaCaT-derived 3D skin models.
In 2000, the Rheinwald laboratory developed two immortalized keratinocyte cell lines, called the N/TERT cell 
lines (N/TERT1 and N/TERT2G), generated by transduction of human primary keratinocytes with the human 
telomerase reverse transcriptase (hTERT) gene and by the spontaneous loss of the pRB/p16INK4a cell cycle control 
mechanism11. This cell line was shown to have normal differentiation characteristics in monolayer and organo-
typic skin models. Remarkably, the use of the HaCaT cell line prevailed in experimental dermatological research 
and to date a limited number of studies have used N/TERT keratinocytes. (See Table 1 for studies using organo-
typic skin models and Supplemental Table 1 for studies using N/TERT cells in conventional monolayer cultures). 
Unfortunately, a direct comparison of N/TERT keratinocytes to primary human keratinocytes is lacking and 
this may have hampered the wide implementation of the N/TERT keratinocyte cell line in biomedical research. 
In addition, in toxicological research, the HEE models: SkinEthic26, EpiDerm27, and EPISKIN28 are accepted 
alternatives for skin irritation and corrosion testing. Herein, the N/TERT cell line could be a valuable substitute 
for primary keratinocytes, however studies on N/TERT cells in HEE models are scarce17,18,21–23 and a thorough 
characterization with regard to epidermal differentiation and response to inflammatory mediators is lacking.
Earlier studies by our group and others showed that the addition of T-helper-(Th)1 or Th2 cytokines to 3D 
skin models induce a phenotype in keratinocytes that is similar to psoriasis (PS) or atopic dermatitis (AD), 
respectively29–31. PS and AD are highly prevalent multifactorial chronic inflammatory skin diseases of which PS is 
considered to be Th1-Th17 immune cell mediated, while in AD the Th2 cells and cytokines prevail. Current treat-
ment is often aimed at general immunosuppression, which is associated with side effects. Therefore, an unmet 
medical need exists for novel targeted, therapeutic approaches. In vitro inflammatory skin disease models are 
considered valuable tools to study disease pathogenesis and can be used in a pre-clinical drug screening setting. 
However, the large-scale production and implementation of these models is lacking and this may be due to the 
limited source of primary keratinocytes. The N/TERT keratinocyte cell lines could provide a solution herein, 
but only if their response to inflammatory mediators such as Th1, Th2, and Th17 cytokines is similar to that of 
primary keratinocytes.
To illustrate the potential of N/TERT keratinocytes for studies on epidermal biology, inflammatory skin dis-
ease pathogenesis and therapeutics, we compared the mRNA and protein expression of two N/TERT keratino-
cyte cell lines to that of human primary epidermal keratinocytes in monolayer cultures. Next, we generated a N/
TERT-HEE model and characterized mRNA and protein expression, and physical barrier properties of this 3D 
epidermal model by a comparison to HEEs generated from primary keratinocytes. PS-associated (Th1 and Th17) 
or AD-associated (Th2) cytokines were used to generate 3D human skin inflammation models and we validated 
disease markers in both models by known anti-inflammatory drugs.
Results
Karyotyping and short tandem repeat analysis of N/TERT keratinocytes. The N/TERT1 and N/
TERT2G keratinocytes were karyotyped to assess their ploidy according to standard procedures. N/TERT2G is 
diploid (46, XY) and N/TERT1 is diploid with an additional chromosome 20 (47, XY, +20) (Supplemental Fig. 1). 
To assess potential contamination with other cells, short tandem repeat (STR) analysis was performed by quan-
titative fluorescence (QF)-PCR using 21 specific targets on chromosome 13, 18, 21, and both sex chromosomes 
3D skin model Dermal matrix F Epidermal morphology Field of study Reference
HSE Collagen type I Y Stratified epidermis, sc present Cell line development Dickson et al.11 $
HSE Collagen type I Y Stratified epidermis, sc present Cell line development Rheinwald et al.12
HSE DED Y Stratified epidermis, sc present Epidermal biology Wan et al.6
HSE DED Y Stratified epidermis, sc present Skin barrier Man et al.13
HSE Collagen type I Y Stratified epidermis, sc present Epidermal biology Dabelsteen et al.14
HEE None N Stratified epidermis, sc present UV radiation, DNA damage Bertrand-Vallery et al.15
HSE Collagen type I N Stratified epidermis, sc present Human papillomavirus Lazic et al.16
HEE None N Stratified epidermis, sc present Epidermal biology Robertson et al.17
HSE Collagen type I Y Stratified epidermis, sc present Skin barrier Van Drongelen et al.18
HSE Collagen type I Y Multilayer of cells, sc lacking UV radiation, DNA damage Harrison et al.19
HSE Collagen type I Y Multilayer of cells, sc present Ionizing radiation, DNA damage Acheva et al.20
HSE Collagen type I Y Stratified epidermis, sc present Skin barrier Van Drongelen et al.21
HEE None N Stratified epidermis, sc present Epidermal biology Van Drongelen et al.22
HEE None N Stratified epidermis, sc present Skin sensitization Alloul-Ramdhani et al.23
HSE Matriderm Y Stratified epidermis, sc present Epidermal biology Reijnders et al.24
HSE Collagen type I Y Stratified epidermis, sc present Ionizing radiation, inflammation Acheva et al.25
Table 1. Studies using in vitro 3D reconstructed skin generated from N/TERT keratinocytes. $Initial paper 
describing the N/TERT cell line development; HSE: human skin equivalent; HEE: human epidermal equivalent; 
DED: de-epidermized dermis; F: Fibroblasts present Yes/No; UV: ultraviolet; sc: stratum corneum.
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X and Y (Supplemental Fig. 2). All targets, except D18S391, are informative and rule out cellular contamination. 
Only N/TERT1 is shown, as both N/TERT keratinocytes showed identical results.
Differentiation kinetics and dynamics of N/TERT keratinocytes in conventional cultures. To 
evaluate the differentiation dynamics of the N/TERT1 and N/TERT2G keratinocytes we performed a time course 
and compared N/TERT keratinocytes to primary human keratinocytes. We analysed epidermal differentiation 
gene expression levels in monolayer cultures up to seven days of differentiation. Relative expression levels of N/
TERT keratinocytes were normalized to primary keratinocytes, giving an insight into the basal expression levels 
and expression patterns of N/TERT keratinocytes at different time points (Fig. 1, t = 0, 2, 4 and 7 days of differ-
entiation). At confluency, which is the start of the differentiation phase (t = 0) due to cell-cell contact inhibition, 
the basal expression level of all investigated epidermal genes was significantly lower in N/TERT keratinocytes 
(terminal differentiation genes: filaggrin (FLG), loricrin (LOR), involucrin (IVL), late cornified envelope (LCE) 1A; 
keratins (KRT): KRT1, KRT5, KRT14, KRT16; and genes involved in cornification and desquamation: transglu-
taminase (TGM) 1, TGM3, cystatin M/E (CST6)). Expression levels increased at day 2 and at day 4 the expression 
of FLG, LOR, IVL, TGM3, CST6, LCE1A was significantly higher in the N/TERT keratinocytes as compared to 
primary keratinocytes, indicating a significantly stronger induction rate of N/TERT keratinocytes from day 0 
to day 4. The N/TERT keratinocyte gene expression levels reached a maximum at day 4 and dropped below the 
primary keratinocyte levels at day 7. Primary keratinocytes tend to reach their highest expression levels not ear-
lier than at day 7. These results indicate that the N/TERT keratinocytes respond very strongly to differentiation 
stimuli and reach similar expression levels of terminal differentiation genes as primary keratinocytes, albeit at an 
earlier time point in culture.
Human epidermal equivalents can be generated from human N/TERT keratinocytes. To study 
the potential of N/TERT keratinocytes for the implementation in 3D skin model development, we optimised 
N/TERT HEE culture protocols (Supplemental Fig. 3) and studied the epidermal stratification and functional 
characteristics herein. Briefly, using K-SFM medium (as compared to DMEM which is used in primary keratino-
cyte HEE cultures) during the proliferation phase of the culture period and CnT-PR-3D medium supplemented 
with DMEM (60:40) in the differentiation phase resulted in most optimal epidermal morphology (Supplemental 
Fig. 4A). Furthermore, the seeding of approximately 1·105 N/TERT cells (Supplemental Fig. 4B) directly from 
liquid nitrogen (passage 0) or cultured cells until passage 4 (Supplemental Fig. 4C) generated high quality HEEs 
where N/TERT keratinocytes generated a multilayered epidermis with presence of a stratum granulosum and a 
basket weave stratum corneum in approximately 10 days of air-exposed culture (Fig. 2A). Using immunohisto-
chemistry we studied the expression of epidermal differentiation protein FLG, the expression of the proliferation 
marker Ki67, and the expression of anti-microbial peptides human beta defensin 2 (hBD2), and skin-derived 
antileukoprotease (SKALP). We compared the expression patterns with HEE cultures generated from primary 
human keratinocytes and found highly similar protein expression patterns, apart from a lower expression of FLG 
Figure 1. N/TERT keratinocytes express terminal differentiation genes. mRNA expression of epidermal 
differentiation genes by N/TERT keratinocyte monolayer cultures (N = 3 for N/TERT 1 and N/TERT2G) were 
compared to primary keratinocytes (N = 6 donors). Bars represent mean ± SEM. *p < 0.05 relative to primary 
keratinocyte at the same time point.
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and stronger expression of SKALP in the N/TERT-HEEs (Supplemental Fig. 4D,E). To analyse the stratum cor-
neum barrier characteristics of N/TERT keratinocyte-based 3D HEEs we performed ‘outside-in’ (Lucifer Yellow 
(LY)) and ‘inside-out’ (EZ-Link Sulfo-NHS-LC-LC-Biotin) tracer penetration assays, as previously reported32. We 
found restricted dye penetration from day 6 of the air-liquid interphase culture onwards (Fig. 2B). These findings 
correspond to data obtained with HEEs generated from primary human keratinocytes32.
Human N/TERT and primary keratinocytes respond similar to pro-inflammatory cytokine 
stimulation in conventional monolayer cultures. Next, the expression levels of terminal differentia-
tion genes and inflammatory disease marker genes were analysed in monolayer N/TERT keratinocytes that were 
stimulated with pro-inflammatory Th1 or Th2 cytokines. Upon stimulation with Th1 cytokines (TNFα, IFNγ, 
and IL-1α) the expression levels of FLG and LOR decreased (normalized to unstimulated keratinocytes) and in 
particular in N/TERT2G keratinocytes this downregulation was significantly stronger as compared to primary 
keratinocytes (Fig. 3A). The expression of psoriasis-related host defence genes PI3 and DEFB433–35 (encoding 
SKALP/elafin and hBD2, respectively) was increased in both primary and N/TERT keratinocytes, but N/TERT 
keratinocytes showed a significantly stronger upregulation and this was most pronounced in N/TERT2G cultures 
(Fig. 3B). After stimulation with Th2-cytokines (IL-4 and IL-13), we observed a minor decrease (only statistically 
significant for FLG) in FLG, LOR and IVL expression in N/TERT keratinocytes (Fig. 3C), while markers for 
AD, C-C motif chemokine ligand 26 (CCL26) and carbonic anhydrase 2 (CA2)30,36, were found to be upregulated 
(Fig. 3D). Overall, the N/TERT keratinocytes appear more responsive to Th1 cytokine stimulation than primary 
keratinocytes. Upon addition of Th2 cytokines, N/TERT1 keratinocytes express less CA2 than primary keratino-
cytes and N/TERT2G keratinocytes. CCL26 is upregulated by both N/TERT cell lines and the primary keratino-
cytes upon Th2 cytokine addition, albeit a stronger induction rate of primary keratinocytes. These differences are, 
however, not statistically significant due to the high interdonor variability of the primary keratinocytes.
Psoriasis-like HEE model (PS-HEE) generated from N/TERT keratinocytes. We explored the 
potential of N/TERT keratinocytes for generating in vitro inflammatory skin models for psoriasis by the addition 
of pro-inflammatory cytokines to N/TERT-HEEs. We added psoriasis-associated cytokines of Th1 (TNFα, IL-6, 
and IL-1α) and Th17 (IL-17 and IL-22) origin to N/TERT1 HEEs during the last three days of the air-liquid inter-
phase culture. We furthermore aimed to rescue the disease phenotype by the addition of all trans retinoic acid 
(ATRA), an anti-psoriatic drug, to the culture medium supplemented with Th1 or Th17 cytokines as previously 
described for primary keratinocyte 3D skin models31,37.
Upon Th1 and Th17 cytokine stimulation we found a strong and significant decrease in the expression of 
FLG and LOR, while IVL expression was upregulated by Th1 cytokines (Fig. 4A,B). ATRA treatment successfully 
Figure 2. N/TERT1 keratinocytes are suitable for culture in HEE models. (A) Haematoxylin Eosin (HE) 
staining of N/TERT1 keratinocytes in the HEE model system while developing from day 2 to day 10 of air 
exposure. (B) Epidermal barrier properties of the HEE constructs by biotin penetration (red) and Lucifer yellow 
penetration (green). Scale bar = 100 µm.
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rescued FLG expression levels after the Th1 cytokine stimulation, but also significantly altered FLG, LOR and IVL 
expression alone. Both Th1 and Th17 cytokines significantly induced the expression of the host defence genes PI3 
and DEFB4 (Fig. 4B,E). This closely resembles the transcriptional expression patterns that are found in psoriasis 
lesions in vivo38–40. ATRA treatment reduced the expression of PI3 and DEFB4 in Th1 and Th17 cytokine stimu-
lated N/TERT-HEEs to levels that are close to the control situation (Fig. 4B,E).
Th1 and Th17 cytokines affected the epidermal morphology as haematoxylin eosin stainings showed paraker-
atosis (retained nuclei in the stratum corneum), thickening of the stratum corneum and the absence of a stratum 
granulosum in these cultures (Fig. 4C,F), all features of psoriatic skin. Treatment with ATRA improved the epider-
mal morphology in both cytokine models (Fig. 4C,F). The changes in epidermal morphology were accompanied 
by lowered protein expression levels of the terminal differentiation protein FLG, while psoriasis markers hBD2 
and SKALP were upregulated. ATRA treatment lowered hBD2 and SKALP expression but did not restore FLG 
protein levels (Fig. 4G and Supplemental Fig. 5). These results indicate that N/TERT cells can be used to generated 
PS-HEEs and we were able to validate the model by the treatment with a known anti-psoriatic drug.
Atopic dermatitis-like HEE model (AD-HEE) generated from N/TERT keratinocytes. We used 
the Th2 cytokines IL-4 and IL-13 to induce histopathological and molecular hallmarks of AD. These include acan-
thosis, spongiosis, and apoptosis41–43 and disease-associated gene and protein expression patterns in HEEs gener-
ated from N/TERT1 and N/TERT2G keratinocytes. To explore the potential of the N/TERT atopic dermatitis-like 
inflammatory HEE model (AD-HEE) model for pre-clinical drug screening, we used coal tar as a therapeutic 
model agent. Coal tar therapy is an ancient treatment for AD and psoriasis44,45 and we recently uncovered its 
molecular mechanism of action, namely activation of the aryl hydrocarbon receptor (AHR)46. The well known 
AHR target gene, cytochrome p450 family member 1A1 (CYP1A1)47 is strongly induced by primary keratinocytes 
after coal tar exposure48 and N/TERT keratinocytes respond in a similar manner (Fig. 5A, Supplemental Fig. 6A). 
Other AHR target genes like 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inducible poly(ADP-ribose) polymer-
ase (TIPARP), cytochrome p450 family member 1B1 (CYP1B1), aryl hydrocarbon receptor repressor (AHRR) 
(Supplemental Fig. 6A) and epidermal differentiation genes, IVL and HRNR (Supplemental Fig. 6B) were also 
induced in N/TERT keratinocytes after coal tar stimulation while the expression of AD-related genes30,49 CCL26 
and CA2 were significantly upregulated in the N/TERT AD-HEE (Fig. 5B). Epidermal morphology of N/TERT 
AD-HEEs showed signs of spongiosis in the suprabasal layers (intercellular oedema, seen as white spaces between 
adjacent cells in the HE staining) (Fig. 5C, panel HE, arrowheads) and apoptotic basal cells (Fig. 5C, panel 
TUNEL). Coal tar treatment reduced the histopathological AD hallmarks but did not rescue the Th2-cytokine 
mediated downregulation of epidermal differentiation proteins, FLG, IVL and LOR (Fig. 5D).
Figure 3. N/TERT keratinocytes and primary keratinocytes respond similar to pro-inflammatory cytokine 
stimulation in conventional monolayer cultures. (A) Terminal differentiation genes and (B) psoriasis marker 
mRNA expression of monolayer N/TERT keratinocytes and primary keratinocytes after stimulation with Th1 
cytokines (IL-1α, TNFα, and IFNγ). (C) Terminal differentiation genes and (D) AD marker mRNA expression 
of monolayer N/TERT keratinocytes and primary keratinocytes after stimulation with Th2 cytokines (IL-4 and 
IL-13). Bars represent mean ± SEM. *p < 0.05 **p < 0.01 ***p < 0.001 relative to primary keratinocytes.
www.nature.com/scientificreports/
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Discussion
Immortalized human cell lines have been instrumental for scientists to validate data obtained in animal mod-
els and for the translation to human biology and disease. Yet, the demand for complex tissue-like cell culture 
models to better represent the in vivo situation is ever rising. In skin research, organotypic 3D skin models are 
Figure 4. N/TERT1 keratinocytes are suitable to generate a psoriasis-like HEE (PS-HEE) disease model. (A,B) 
N/TERT HEEs were harvested for mRNA expression analysis and (C) morphological analysis after stimulation 
with Th1 cytokines (TNFα, IL-6, and IL-1α) and rescued by addition of all trans retinoic acid (ATRA). (D,E) N/
TERT HEEs were harvested for mRNA expression analysis and (F,G) morphological analysis after stimulation 
with Th17 cytokines (IL-17 and IL-22) and rescued by addition of all trans retinoic acid (ATRA). Images are 
representative of N = 3 N/TERT HEE experiments. Bars represent mean ± SEM. *p < 0.001 **p < 0.01 relative 
to control unstimulated keratinocytes. Scale bar = 100 µm.
www.nature.com/scientificreports/
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nowadays considered the gold standard, however, the use of primary human keratinocytes is herein required to 
obtain optimal tissue morphology. High costs for commercially available primary cells and the large quantity 
of cells needed to generate 3D skin models have directed research groups to isolate primary keratinocytes from 
surplus skin. Unfortunately, the availability of donor skin is limited and high inter-donor variability requires 
a multitude of biological replicates for a good reproducibility of results. Immortalized N/TERT keratinocytes 
are diploid (Supplemental Figs 1 and 2) with the exception of an additional chromosome 20 in the N/TERT1 
keratinocyte cell line. A gain of chromosome 20 is related to increased proliferative potential and often observed 
in immortalized cells and in several cancer cell lines48,50–54. Nevertheless, both N/TERT keratinocytes mimic 
major characteristics of primary human keratinocytes and have superior qualities over the most widely used 
Figure 5. N/TERT1 keratinocytes can be used to generate a atopic dermatitis-like HEE (AD-HEE) disease 
model. (A) mRNA expression of N/TERT1 HEEs after coal tar stimulation. Activation of the aryl hydrocarbon 
receptor (AHR) is measured via the induction of the AHR target gene, CYP1A1. (B) N/TERT HEEs were 
harvested for mRNA and (C) morphological analysis after stimulation with Th2 cytokines (IL-4 and IL-13) and 
rescued by addition of coal tar extract. (D) Protein expression was visualised by immunohistochemistry. Bars 
represent mean ± SEM. *p < 0.05 **p < 0.01 ***p < 0.001. Scale bar = 100 µm.
www.nature.com/scientificreports/
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HaCaT (aneuploid5) keratinocyte cell line with regard to epidermal differentiation and the formation of a strati-
fied epithelium. The herein provided literature overview of research utilizing N/TERT keratinocytes (Table 1 and 
Supplemental Table 1) enables others to determine the suitability of the N/TERT keratinocytes for their research.
Besides the use of HaCaT cells, the use of the Rho kinase inhibitor, Y-27632, was demonstrated to generate 
immortalized epithelial cell lines55. Although it is possible to generate immortalized primary foreskin keratino-
cytes, and to prolong the life span of adult keratinocytes through the use of Y-2763255,56, cells require the inhibitor 
throughout the cell culture. Since Rho kinases are vital for many cellular processes, potential off-target effects may 
occur. In addition, the adult keratinocytes are not stably immortalized by the Rho kinase inhibition and senes-
cence occurs after five to eight passages. Therefore, this method seems less suitable for experiments that require 
extensive cell handling, sorting and prolonged subcultures.
The initial study first describing the N/TERT1 and N/TERT2G cell lines11 already showed the potential of N/
TERT keratinocytes to retain normal growth and differentiation characteristics in vitro. These data together with 
the herein presented direct comparison to human primary keratinocytes clearly indicate that N/TERT keratino-
cytes largely behave like primary keratinocytes. N/TERT keratinocytes tend to differentiate quicker than primary 
keratinocytes as shown by the gene expression peaks at day 4 of differentiation in N/TERT keratinocytes and at 
day 7 of differentiation in primary human keratinocytes (Fig. 1). Therefore, when using N/TERT keratinocytes 
in a monolayer culture system, one should be cautious about the time of harvesting when differentiation status is 
critical for the experimental outcome.
Since the introduction of the N/TERT cell line seventeen years ago, we only found sixteen papers describ-
ing the use of these cells in the development of organotypic human skin models (Table 1). The majority have 
used a dermal substrate based on collagen, fibroblasts or human decellularized dermis. Only four studies15,17,22,23 
have generated an epidermis only model from N/TERT keratinocytes, similar to the commercially available 
SkinEthic26, EpiDerm27, and EPISKIN28 whom are generated from primary human keratinocytes. A thorough 
characterization of epidermal morphology, differentiation, and barrier function of N/TERT HEEs was still lack-
ing, hence the current study. We found that both N/TERT cell lines (N/TERT1 and N/TERT2G) generate HEEs 
that are similar to primary keratinocyte-based HEEs. The only protein that is absent in normal skin, yet detected 
in N/TERT HEEs is SKALP. This antimicrobial protein is involved in keratinocyte host defence responses and 
highly upregulated in psoriasis skin57. The expression of SKALP in organotypic skin cultures is however not 
unusual31. N/TERT keratinocytes are derived from primary neonatal foreskin keratinocytes, which are known for 
higher expression levels of SKALP in comparison to primary adult keratinocytes31.
We found the basket weave stratum corneum of N/TERT HEEs to form a functional barrier to low molecular 
weight tracers (Fig. 2A,B) that are widely used for studying the outside-inside and inside-outside barrier func-
tion of the in vitro reconstructed epidermis32,58. The stratum corneum lipid composition and ultrastructure of 
N/TERT HSEs has been studied by the group of El Ghalbzouri21, showing a high similarity to HSEs generated 
from primary human keratinocytes. Although we cannot exclude potential differences between N/TERT and 
primary keratinocytes for the penetration of other tracer molecules or microbial components, and differences 
between the stratum corneum formation in HSE versus HEE models may occur, N/TERT keratinocytes show a 
great potential substituting primary keratinocytes in 3D reconstructed models for normal skin. Important to note 
is that the HEE culture model system should not be considered as a full thickness skin model, but as an epidermal 
equivalent. The inert plastic filter obviously does not replicate the functions of the native basement membrane 
and the absence of a dermal matrix also precludes investigations on dermal-epidermal interactions. Other groups 
already showed the feasibility of generating full thickness skin equivalents using N/TERT cells18,21,23, therefore 
we focussed on the application of the N/TERT cells in the epidermal only models and models for inflammatory 
skin diseases. Altogether the N/TERT keratinocytes are now described in different culture models for human 
skin, using diverse culture protocols by various research groups. This clearly indicates the good reproducibility of 
data obtained from N/TERT cells and strengthens the notion that this cell line is a powerful tool in experimental 
dermatology research.
To date, no studies investigated the feasibility of using the N/TERT-HEEs for studies on inflammatory skin dis-
eases. Psoriasis and atopic dermatitis are highly prevalent, inflammatory skin disease of multifactorial aetiology 
but with a distinct disease pathophysiology. Increased proliferation, lack of a stratum granulosum and parakera-
tosis (retention of nuclei in the stratum corneum resulting from incomplete keratinocyte maturation59) are mor-
phological hallmarks of psoriatic skin60–62. Epithelium-specific genes like DEFB4, PI3, S100A7, and KRT16 and 
their corresponding proteins are highly expressed in psoriatic epidermis and are considered disease markers57,63. 
The immunological component of psoriasis is marked by high levels of pro-inflammatory cytokines and chemok-
ines, including interferon-γ, interleukins 1, 6, 17, and 22 and tumor necrosis factor (TNF)α64–69. Addition of 
the abovementioned pro-inflammatory cytokines to human primary keratinocytes is frequently described to 
generate in vitro models for psoriatic skin31,70–74. We found that the addition of Th17 cytokines, IL-17 and IL-22, 
to the N/TERT-HEEs most closely resembled psoriasis skin: presence of parakeratosis, lack of a stratum gran-
ulosum (and thus low levels of FLG and LOR), and induced levels of hBD2 and SKALP (Fig. 4G). The addition 
of Th1 cytokines (TNFα, IL-6, and IL-1α) resulted in similar effects, yet these cytokines had more deleterious 
effects on the epidermis resulting in less optimal epidermal morphology (Supplemental Fig. 5). As we intended 
to compare the responses of N/TERT keratinocytes to primary keratinocytes, we applied the cytokine cocktails 
used for primary keratinocytes and did not optimise concentrations or combinations which may improve the 
epidermal morphology of the Th1 model. Other psoriasis hallmarks, like the presence of rete ridges, microab-
cesses of Munro, pustules of Kogoj, and aberrations of dermal capillaries60,75 can obviously not be studied in our 
model, as it lacks a dermal compartment with immune cells and blood vessels. Of note, the N/TERT PS-HEE 
does not show acanthosis or hyperproliferation. Since the majority of primary keratinocyte-derived organotypic 
skin models lack these features, this seems a problem inherent to the skin- or epidermis equivalent model system 
used, and not the source of keratinocytes. The only in vitro psoriasis model showing acanthosis due to increased 
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proliferation is a commercially available model27 where normal human keratinocytes are seeded on a collagen gel 
with fibroblasts isolated from lesional psoriatic skin. This suggests that fibroblast-secreted factors, and not T-cell 
derived cytokines, might be a source of keratinocyte mitogens.
Histological examination of AD skin shows dermal infiltrates that are mainly comprised of Th2-helper cells 
that produce IL-4 and IL-1376. Like in psoriasis, IL-17 also plays a role in AD pathophysiology77. However, novel 
systemic therapies are aimed at the Th2-mediated inflammation and phase 3 clinical trials on a human mon-
oclonal antibody (Dupilimab) against IL-4 receptor alpha that inhibits signaling of IL-4 and IL-13 have been 
completed recently78. IL-4 signaling reduces expression of important skin barrier proteins, like FLG, LOR, and 
IVL46,79–83, which is thought to be correlated to the impaired skin barrier function in AD84–86. This, however, is of 
recent controversy since FLG null mutations and a complete absence of LOR and IVL does not diminish barrier 
properties of HEEs32. We were able to generate an AD-like phenotype in our N/TERT AD-HEE by stimulating 
with IL-4 and IL-13 during the final three days of the air-liquid interphase culture (Fig. 5). The similar effects on 
N/TERT keratinocytes as compared to primary keratinocytes on downstream target genes by the herein inves-
tigated pro-inflammatory cytokines, suggest that the signalling pathways involved in the Th1, Th17, and Th2 
mediated pathogenesis, like the JAK/STAT87 and NF-ĸB88 pathways are functional in both N/TERT keratinocyte 
cell lines.
In both N/TERT HEE disease models, established drugs targeting the epidermal keratinocyte compartment 
successfully reduced inflammation hallmarks suggesting a place for N/TERT keratinocytes in drug development 
or screening pipelines. ATRA is a widely used anti-psoriatic drug and binds to nuclear receptors, retinoic acid 
receptor (RAR) and retinoid X receptor (RXR) in the epidermis89. Coal tar activates the AHR leading to a damp-
ened Th2 cytokine-mediated inflammatory response and the reduction of spongiosis and apoptosis46. Research in 
the field of AHR signalling has been rapidly emerging in the past years. This ligand-activated transcription factor 
is a master regulator of pivotal cell biological processes like xenobiotic metabolism, cell proliferation, differen-
tiation, and migration in a variety of cells and tissues (reviewed by Esser et al.90). In the skin, the AHR regulates 
epidermal proliferation, differentiation, melanogenesis, wound healing, response to UV radiation, and immune 
responses91. AHR activation in N/TERT keratinocytes results in upregulated expression of known target genes 
CYP1A1, CYP1B1, TIPARP (Fig. 5A, Supplemental Fig. 6A) and negative feedback repressor gene AHRR, which 
opens up avenues to use the N/TERT cells as a convenient and unlimited cell source of human keratinocytes to 
study AHR-related mechanisms in the skin.
One other important field for which the N/TERT keratinocytes could be an immensely valuable asset is 
genome editing. The CRISPR/Cas9 system, first introduced for mammalian cell genome editing in 201392, now 
facilitates virtually unlimited genetic manipulation and is described in studies on cell biology, disease patho-
physiology, drug screening, and therapeutic interventions. In vitro technologies based on CRISPR/Cas9 require 
serial passaging of transfected cells and clonal cultures for the selection of your desired genotype. Primary cells 
with a limited life span are therefore not suitable for genome editing strategies and studies with CRISPR/Cas9 in 
skin biology or diseases remain scarce93,94. The unlimited lifespan, diploid nature and high similarity to primary 
keratinocytes make N/TERT keratinocytes the ideal cell source for genome editing studies.
Altogether, this work directs towards an expanded utilization of the N/TERT cell lines as a substitute for pri-
mary cells in biologically relevant applications in the fields of cell biology, tissue engineering, dermatology, and 
toxicology.
Methods
N/TERT keratinocytes karyotyping and short tandem repeat (STR) analysis. The N/TERT 
keratinocytes were karyotyped to assess chromosome abnormalities. In short, colcemid (Invitrogen, New 
York, USA) treated, hypotonic N/TERT keratinocytes were fixed by methanol:acetic acid (3:1) before Giemsa-
staining on glass slides. Metaphases were analysed under light microscope by Clinical Assistant (RVC, Baarn, 
The Netherlands). Additional short tandem repeat (STR) analysis, to assess the cell lines purity, was performed 
by QF-PCR using the Aneufast QF-PCR kit (molGENTIX, Barcelona, Spain) according to the manufacturers 
protocol. Electrophoretograms were generated by use of GeneMarker (SoftGenetics LLC, Stage College, USA).
Isolation of primary human keratinocytes. Human abdominal or breast skin was obtained from plastic 
surgery procedures after informed consent and in line with the principles and guidelines of the Declaration of 
Helsinki. Skin biopsies were taken and human primary keratinocytes were isolated as previously described31 and 
stored in liquid nitrogen until further use.
Monolayer cultures of human primary keratinocytes and human N/TERT keratinocytes. 
Human primary keratinocytes (P1) were cultured in a 24 wells plate in keratinocyte growth medium (Lonza, 
Walkersville, USA) until near 100% cell confluence before stimulation with either Th1 (TNFα (30 ng/mL), IFNγ 
(500 U/mL) and IL-1α (30 ng/mL)), Th2 (IL-4 (50 ng/mL) and IL-13 (50 ng/mL)), or Th17 (IL-17 (50 ng/mL) and 
IL-22 (50 ng/mL)) cytokines. All cytokines were obtained from Preprotech, London, UK. Two human N/TERT 
keratinocyte cell lines (N/TERT-1 and N/TERT-2G), purchased from J. Rheinwald laboratory (Harvard Medical 
School, Boston, USA), were cultured in a 24 well plate in keratinocyte-serum free medium (K-SFM, Gibco) until 
50% confluence when switched to experiment medium (50% K-SFM and 50% DF-K (DMEM:Ham’s F12, 1:1 (vol/
vol) with added bovine pituitary extract (BPE, 25 µg/mL, Invitrogen,) L-glutamine (2mM, Invitrogen), EGF (0.2 ng/
mL, Invitrogen) and CaCl2 (300 µM, Sigma-Aldrich, Saint Louis, USA), as described by Dickson et al.11. Stimulation 
with Th1, Th2 and Th17 cytokines (in concentrations mentioned above) was performed near 100% cell confluence. 
Cells were harvested 24, 48, and 72 hours post stimulation for quantitative gene expression analysis.
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Human epidermal equivalent (HEE) generation. N/TERT-HEEs were generated as previously 
described32,95 with few modifications (Supplemental Fig. 3). Briefly, inert transwells (ThinCerts, Greiner Bio-One 
GmbH) were coated with rat tail collagen (100 µg/mL, BD Biosciences, Bedford, USA) at 4 °C for 1 hour. 105 
N/TERT1 or N/TERT2G keratinocytes were seeded on the transwells in 100 µL K-SFM medium (Gibco) in 
a 24 wells format. After 48 hours, cultures were switched to a mixture of CnT-PR-3D medium (CELLnTEC, 
Bern, Switzerland) and DMEM medium (60:40 (v/v)) for 24 hours and then cultured at the air-liquid interface 
for 10 days. Culture medium was refreshed every other day. Optimisation of the culture protocol is shown in 
Supplemental Fig. 4A–C.
Psoriasis (PS) and atopic dermatitis (AD) HEE development. N/TERT-HEEs were generated as 
described above (Supplemental Fig. 3A). From day 7 to 10 of the air-liquid interphase culture, PS-associated or 
AD-associated cytokines were added to the cultures (Supplemental Fig. 3B). For the PS model, Th1 cytokines, 
TNFα (5 ng/mL), IL-6 (5 ng/mL) and IL-1α (10 ng/mL) or Th17 cytokines IL-17 (30 ng/mL), and IL-22 (30 ng/
mL) were used. The AD model was generated by adding the Th2 cytokine IL-4 (10 ng/mL) to the culture media. 
The PS or AD phenotype in HEEs was rescued by addition of all trans retinoic acid (ATRA, 1 µM, Sigma-Aldrich) 
or a coal tar extract (prepared from crude pix lithanthracis, Fagron BV, Capelle aan den IJssel, Netherlands), 
respectively at day 8 of the culture experiment (Supplemental Fig. 3C). At day 10, N/TERT-HEEs were harvested 
for gene expression analysis and immunohistochemistry.
Total RNA isolation and quantitative real-time polymerase chain reaction. Total RNA was iso-
lated using the Favorprep total tissue RNA kit (Favorgen Biotech, Taiwan), according to the manufacturers pro-
tocol. cDNA was generated, after DNase treatment, and used for quantitative real-time PCR (qPCR) by use of 
the MyiQ Single-Colour Real-Time Detection System (Bio-Rad laboratories, Hercules, USA) for quantification 
with Sybr Green and melting curve analysis. All primers (Table 2) were obtained from Biolegio (Nijmegen, The 
Netherlands). Target gene expression levels were normalized to the expression of human acidic ribosomal phos-
phoprotein P0 (RPLP0). The relative expression levels of all genes of interest were measured using the 2−ΔΔCT 
method96.
Morphological and immunohistochemical analysis. HEEs were fixed in 4% formalin solution for 4 
hours and subsequently embedded in paraffin. 6 µm sections were stained with hematoxylin and eosin (H&E, 
Sigma-Aldrich) or processed for immunohistochemical analysis. Sections were blocked for 15 minutes with 
5% normal goat, rabbit, or horse serum in phosphate-buffered saline (PBS) and subsequently incubated with 
the antibodies mouse anti-FLG, rabbit anti-LOR, mouse anti-IVL, mouse anti-Ki67, goat anti-hBD2, or rabbit 
anti-SKALP/Elafin for 1 hour at room temperature. Next, a 30 minute incubation step with biotinylated rabbit 
anti-goat, horse anti-mouse, or goat anti-rabbit (Vector Laboratories, Burlingame, USA) was performed, followed 
by a 30 minute incubation with avidin-biotin complex (Vector laboratories). The peroxidase activity of 3-Amino-
9-ethylcarbazole (AEC) was used to visualize the protein expression and the sections were mounted using glyc-
erol gelatin (Sigma-Aldrich). See Table 3 for details on the antibodies used.
Gene Name Forward primer (5′–3′) Reverse primer (5′–3′) E*
FLG Filaggrin acttcactgagtttcttctgatggtatt tccagacttgagggtctttttctg 1.89
LOR Loricrin aggttaagacatgaaggatttgcaa ggcaccgatgggcttagag 2.08
IVL Involucrin acttatttcgggtccgctaggt gagacatgtagagggacagagtcaag 1.93
HRNR Hornerin tacaaggcgtcatcactgtcatc atctggatcgtttggattcttcag 2.12
LCE1A Late cornified envelope 1 A tgcaagagtggctgagatgc agacaacacagttggtgtcagg 2.18
KRT1 Keratin 1 gatgaaatcaacaagcggacaa tggtagagtgctgtaaggaaatcaatt 2.24
KRT5 Keratin 5 atctctgagatgaaccggatgatc cagattggcgcactgtttctt 2.26
KRT14 Keratin 14 ggcctgctgagatcaaagactac cactgtggctgtgagaatcttgtt 1.93
KRT16 Keratin 16 gatcattgcggccaccat tgctcatacttggtcctgaagtca 2.01
TGM1 Transglutaminase 1 cccccgcaatgagatctaca atcctcatggtccacgtacaca 1.99
TGM3 Transglutaminase 3 ggaaggactctgccacaatgtc tgtctgacttcaggtacttctcatactg 2.06
CST6 Cystatin M/E tccgagacacgcacatcatc ccatctccatcgtcaggaagtac 1.98
CA2 Carbonic anhydrase II aacaatggtcatgctttcaacg tgtccatcaagtgaaccccag 2.02
CCL26 C-C motif chemokine ligand 26 tcattcagtaaagaggcgaagtattatc cagttttttggagggcatctg 1.89
DEFB4 Human beta defensin 2 gatgcctcttccaggtgttttt ggatgacatatggctccactctt 1.99
PI3 Skin-derived antileukoprotease catgagggccagcagctt tttaacaggaactcccgtgaca 2.02
CYP1A1 Cytochrome p450 family 1A1 ctggagaccttccgacactctt gtaaaagcctttcaaacttgtgtctct 2.02
CYP1B1 Cytochrome p450 family 1B1 tggctgctcctcctcttcac ccacgacctgatccaattctg 2.02
TIPARP TCDD inducible polymerase aagctcctccacctcttgaa tctgcagaaacagggacttg 2.05
AHRR Aryl hydrocarbon receptor repressor aaggctgctgttggagtctcttaat gatgtagtcataaatgttctggtgcat 2.15
RPLP0 Ribosomal protein P0 caccattgaaatcctgagtgatgt tgaccagcccaaaggagaag 2.02
Table 2. Primer sequences of all primers. *E is efficiency as fold increase in fluorescence per PCR cycle.
www.nature.com/scientificreports/
1 1ScIentIfIc REPORTS | 7: 11838  | DOI:10.1038/s41598-017-12041-y
Lucifer yellow dye penetration assay. To study the outside-in stratum corneum barrier function, Lucifer 
Yellow (1 mM, Sigma-Aldrich) was applied on top of the HEEs and was allowed to incubate for 60 minutes, in the 
dark, at room temperature32,58. HEEs were fixated in buffered 4% formalin solution, embedded in paraffin and 
sectioned. 6 µm sections were deparaffinised and mounted with Fluoromount-G, containing DAPI (eBioscience 
Inc. San Diego, USA). SDS treatment of the HEEs as a positive control for the Lucifer Yellow penetration upon 
skin barrier disruption was shown in a previous study by our group32.
Biotin penetration assay. To study the inside-out stratum corneum barrier function, the HEEs were turned 
upside down and EZ-link sulfo-NHS-LC-biotin (3.3 mg/mL, Thermo Fisher Scientific, Waltham, USA) was 
applied on the bottom of the filters and allowed to incubate for 60 minutes at room temperature32. HEEs were 
fixated in buffered 4% formalin solution, embedded in paraffin and sectioned. 6 µm sections were deparaffinised 
and incubated for 30 minutes, in the dark, with 1:200 Alexa Fluor 594 streptavidin (Thermo Fisher Scientific) 
conjugate. The sections were mounted with Fluoromount-G containing DAPI.
Statistics. Data are represented as mean ± SEM of at least three technical (N/TERT keratinocytes) or biolog-
ical (primary keratinocytes) replicates. Raw ΔCt values were used to statistically analyze the quantitative PCR 
results using the commercially available SPSS software (IBM SPSS Statistics 22). One-way analysis of variance 
followed by Bonferroni post hoc testing was performed. P < 0.05 was considered to be of statistical significance.
Literature search. A search of relevant literature that reports the use of N/TERT1 and/or N/TERT2G cell 
lines has been conducted in April 2017. A first extensive literature search was performed by investigating all 
publications that cited the original N/TERT paper by Dickson et al.11. From these 229 publications, the abstract 
and materials and methods section was evaluated for the use of N/TERT1 and N/TERT2G cell lines. This led to 
a total of 58 papers, of which 42 studies used the cells in conventional monolayer culture systems (Supplemental 
Table 1) and 16 studies used the cells to generate skin- or epidermal equivalents (Table 1). Furthermore, we used 
Pubmed and Google Scholar and the search terms included ‘N/TERT’, ‘N/TERT1’, ‘N/TERT2G’, ‘TERT’, ‘TRT’, 
‘keratinocytes’, ‘epidermal equivalent’, and ‘skin equivalent’.
Data availability. The datasets generated during and/or analysed during the current study are available from 
the corresponding author on request.
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